Schedule 13D ownership disclosure
TETRALOGIC PHARMACEUTICALS COR
Security class unavailable · CUSIP: 88165U109
Event date: 2015-02-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,644,705
- Percent of class
- 20.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-15-010101
- Form type
- SC 13D
- Filer
- Clarus Lifesciences II, L.P.
- CIK
- CIK 1431443
- Filed
- Feb 13, 2015
- Reporting period
- Feb 12, 2015
- Description
- Schedule 13D beneficial ownership